Top Performing Drug of 2021 - Trulicity (February Edition)
PharmaShots
FEBRUARY 22, 2023
In the US, Trulicity is protected by a compound patent (2027) and by biologics data protection (2026).
PharmaShots
FEBRUARY 22, 2023
In the US, Trulicity is protected by a compound patent (2027) and by biologics data protection (2026).
European Pharmaceutical Review
JUNE 16, 2023
According to Maximize Market Research , new technologies are expected to boost the clinical trials market between 2022 to 2029, especially as the industry and patients are shifting towards digitalisation approaches and personalised medicines.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Viseven
JANUARY 15, 2025
in 2029 , with a compound annual growth rate of 27.9%. In life sciences, chatbots and virtual assistants can be used by pharmaceutical companies to improve communication with patients. The global market for AI in life sciences is projected to reach $33.5b
Hospital Pharmacy Europe
MAY 9, 2024
Communications in infectious diseases In times of global crisis, like the threat of AMR or the Covid-19 pandemic, scientists and healthcare professionals play a crucial role in communicating trusted and relevant information to the public.
Pharmaceutical Technology
JUNE 5, 2023
The US market is driving this growth, forecasted to nearly triple from $2.4bn in 2023 to $7.4bn by 2029, as per GlobalData. Across the seven major markets (US, UK, Japan, Germany, France, Spain and Italy) the market for Parkinson’s disease treatment is set to grow significantly over the next few years, from $4.6bn in 2023 to $11.5bn.
Pharmaceutical Technology
MARCH 7, 2023
billion by 2029, registering a CAGR of over 8% during the forecast period of 2022-2029. Due to rising healthcare spending, launch of novel treatments, and the rise of chronic diseases in an aging population, the global pharmaceutical packaging equipment market is rapidly expanding. Recent analysis valued the market [i] at USD 8.5
Pharmaceutical Technology
MAY 17, 2023
billion in 2029. The condition gradually worsens and can result in liver failure. According to consensus forecasts from GlobalData’s Pharma Intelligence Centre, Ocaliva is forecasted to have global sales of $1.08 GlobalData is the parent company of Pharmaceutical Technology. Please check your email to download the Report.
Let's personalize your content